# DIVISLAB share price, delivery % and history — Divi's Laboratories Limited

> Delivery percentage for Divi's Laboratories Limited (DIVISLAB) against its own history, with 5,849 sessions of split-adjusted NSE data from 2003 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/DIVISLAB

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 9,291.5 INR (-1.48% on the day), 2026-09-30
- Delivery: 63.41% of volume taken to demat (20-day average 63.29%)
- Volume: 5.41L shares, turnover ₹502.9Cr
- Relative volume: 1.09× of its own 20-day average

## Technicals

- RSI(14): 53.27
- ATR(14): 196.5
- SMA 50: 8,770.42, SMA 200: 7,022.87
- 52-week range: 5,636.5 – 9,740 (-4.6% from the high)

## Performance

- 1 week -3.45%, 1 month -1.85%, 3 months 39.04%
- 6 months 54.92%, 1 year 53.55%

## Delivery percentage

- Latest: 63.41% (2026-09-30)
- 20-day average: 63.29%
- 1-year average: 56.26%
- Percentile against its own history: 90th
- Range: 11.09% – 81.92% across 1,728 sessions with a reading

Over the last 20 sessions DIVISLAB settled 63.3% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 56.3%, so recent sessions are running 7.0 points higher than usual. The latest session ranks higher than 90% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 2,46,660.1 crore
- P/E (TTM): 84.33 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 110.18 INR, split-adjusted to match the price series
- Revenue growth: 27.8% YoY, 8.8% QoQ
- Profit growth: 65.5% YoY, 20.11% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 17.13% | 32.19% |
| 3y | 15.49% | 25.57% |
| 4y | 4.96% | -1.48% |
| 5y | 9.3% | 7.37% |
| 6y | 11.13% | 10.62% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 2,338 | 1,722 | 722 | 510 | 19.2 | 21.81% |
| 2024-12-31 | 2,319 | 1,675 | 726 | 589 | 22.2 | 25.4% |
| 2025-03-31 | 2,585 | 1,807 | 864 | 662 | 24.93 | 25.61% |
| 2025-06-30 | 2,410 | 1,796 | 733 | 545 | 20.49 | 22.61% |
| 2025-09-30 | 2,715 | 1,948 | 912 | 689 | 25.97 | 25.38% |
| 2025-12-31 | 2,604 | 1,838 | 780 | 583 | 21.98 | 22.39% |
| 2026-03-31 | 2,831 | 2,023 | 963 | 751 | 28.31 | 26.53% |
| 2026-06-30 | 3,080 | 1,964 | 1,180 | 902 | 33.95 | 29.29% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 51.88%
- Public: 48.12%
- FII: 20.2%, DII: 19.38%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-01: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_181440_01082026125725_iXBRL_WEB.html
- 2026-07-24: dividend
- 2026-07-17: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1695062_17072026025119_WEB.xml
- 2026-05-23: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_160601_23052026181410_iXBRL_WEB.html
- 2026-04-15: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1650975_15042026085225_WEB.xml
- 2026-02-11: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_141843_11022026141612_iXBRL_WEB.html
- 2026-01-09: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1597165_09012026110757_WEB.xml
- 2025-11-07: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_125159_07112025175646_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 115 events are indexed for this instrument.

## About the instrument

- Listed: 2003-03-12 — latest session 2026-09-30 (5,849 sessions)
- ISIN: INE361B01024
- Series: EQ
- Liquidity rank: #45 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)
- [CIPLA](https://patternsradar.com/s/CIPLA.md) — Cipla Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/DIVISLAB.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.